2011
The FDA approved Yervoy (ipilimumab) in March 2011 as the first cancer drug that worked purely by releasing the immune system's brake.
“Yervoy was approved in March 2011. It was a landmark.”
Topic
9 facts from 5 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.
2011
The FDA approved Yervoy (ipilimumab) in March 2011 as the first cancer drug that worked purely by releasing the immune system's brake.
“Yervoy was approved in March 2011. It was a landmark.”
2013
Merck received FDA Breakthrough Therapy Designation for pembrolizumab in January 2013, which BMS's nivolumab did not have.
“Because of that early melanoma data with Pembrolizumab, Merck applied for and got the breakthrough designation in January 2013, a few months before Perimuter arrived on site.”
2014
The FDA granted accelerated approval to pembrolizumab (Keytruda) for advanced melanoma on September 4, 2014.
“On September 4th of 2014, the FDA grants accelerated approval to Pembrolizumab, Keytruda for advanced melanoma.”
2017
Scott Gottlieb served as commissioner of the Food and Drug Administration from 2017 to 2019.
“That's Dr. Scott Gottlieb. He was commissioner of the Food and Drug Administration from 2017 to 2019.”
2017
In 2017 the FDA approved pembrolizumab for any solid tumor with a specific DNA repair defect, the first approval based on a biomarker regardless of tumor origin.
“And in 2017, the FDA approved pembrolizumab for the treatment of any solid tumor with the specific DNA repair defect, regardless of where in the body the cancer originated.”
2020
Ken Griffin says that at the start of the pandemic Citadel helped get FDA approval for experimental COVID drug trials within about 72 hours.
“We moved in about 72 hours to get the FDA to approve experimental drug trials for those with COVID here in the United States.”
2020
Ken Griffin says Operation Warp Speed's key insight was paying pharmaceutical companies to manufacture vaccines before FDA results were known.
“So with Operation Warp Speed, the key insight was pay big pharma to produce vaccines before they have the FDA results.”
2021
Lex Fridman asked Albert Bourla why the FDA had proposed a 75-year timeline to release the Pfizer vaccine data.
“Do you have an intuition about why is the FDA trying to get 75 years to release the Pfizer data?”
Undated
Amodei says the FDA approval process should be sped up because AI-accelerated drug discovery could jam the pipeline, and he calls chatbot-restriction bills stupid.
“I do think we should work to speed the approval process in the FDA.”
Episodes